NCT00166309View on ClinicalTrials.gov

The FEIBA NovoSeven Comparative Study

NACompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

June 30, 2005

Conditions

Severe Hemophilia A With an Inhibitor

Interventions

DRUG

FEIBA and NovoSeven

Trial Locations (1)

SE-205 02

Malmo University Hospital, Malmo

All Listed Sponsors

lead

Skane University Hospital

OTHER

NCT00166309 - The FEIBA NovoSeven Comparative Study | Biotech Hunter | Biotech Hunter